Titan Spine Raises Capital to Support nanoLOCK Interbody Fusion Devices

Titan Spine closed a substantial round of financing for an undisclosed amount with its investor, Southlake Equity. Proceeds will support U.S. sales expansion and surgeon adoption of Endoskeleton® titanium interbody fusion implants and launch of next-generation nanoLOCK™ surface technology. Update, 7/15/16: In Xconomy, Editor...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0